Kitzen Pharmaceutical Consulting, Collegeville, PA, USA
Temple University School of Medicine, Philadelphia, PA, USA
Neumentum, Inc., Palo Alto, CA, USA
NEMA Research, Inc., Naples, FL, USA
University of Arizona College of Pharmacy, Tucson, AZ, USA
Temple University School of Pharmacy, Philadelphia, PA, USA
Copyright © 2018 Jan M. Kitzen, Joseph V. Pergolizzi Jr., Robert Taylor Jr., Robert B. Raffa et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Kitzen, J. , Pergolizzi Jr., J. , Taylor Jr., R. and Raffa, R. (2018) Crisaborole and Apremilast: PDE4 Inhibitors with Similar Mechanism of Action, Different Indications for Management of Inflammatory Skin Conditions.
Pharmacology & Pharmacy,
9, 357-381. doi:
10.4236/pp.2018.99028.